Prostate cancer (PCa) is the most common non-skin malignancy of men in developed countries. In spite of treatment with curative intent up to 30-40% of patients have disease recurrence after treatment, resulting from any combination of lymphatic, hematogenous, or contiguous local spread. The concept of early detection of PCa offer benefits in terms of reduced mortality, but at the cost of over-diagnosis and overtreatment of indolent disease. This is largely due to the random nature of conventional biopsies, with a risk of missing significant cancer and randomly hitting indolent disease. In the present thesis, diagnostic performance of MRI DWI and 11C Acetate PET/CT lymph node staging of intermediate and high risk PCa, was investigated, and a...
BACKGROUND: Contrast-enhanced computed tomography (CT) and magnetic resonance (MR) imaging for lymph...
Background Accurate local staging is critical for treatment planning and prognosis in patients with ...
Despite early detection programs, many patients with prostate cancer present with intermediate- or h...
Prostate cancer (PCa) is the most common non-skin malignancy of men in developed countries. In spite...
Background: C acetate PET/CT parameters in predicting regional lymph node (LN) metastasis of newly d...
PurposeTo determine the clinical value of two novel molecular imaging techniques: 11C-choline positr...
Prostate cancer (PC) is the second most common cancer in men worldwide, affecting ~12%. Although mos...
PURPOSE: To determine the clinical value of two novel molecular imaging techniques: (11)C-choline po...
Introduction: Lymph node metastases (LNM) represent a proven prognostic factor for biochemical recur...
Background: Radiation treatment with simultaneous integrated boost against suspected lymph node meta...
BACKGROUND: Contrast-enhanced computed tomography (CT) and magnetic resonance (MR) imaging for lymph...
Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and the leading cause of ca...
Objectives: We aimed to study the ability of contrast enhanced MRI at 1.5 T and C-11-acetate PET/CT,...
PURPOSE: The detection of lymph-node metastases (N1) with conventional imaging such as magnetic reso...
BACKGROUND: Contrast-enhanced computed tomography (CT) and magnetic resonance (MR) imaging for lymph...
Background Accurate local staging is critical for treatment planning and prognosis in patients with ...
Despite early detection programs, many patients with prostate cancer present with intermediate- or h...
Prostate cancer (PCa) is the most common non-skin malignancy of men in developed countries. In spite...
Background: C acetate PET/CT parameters in predicting regional lymph node (LN) metastasis of newly d...
PurposeTo determine the clinical value of two novel molecular imaging techniques: 11C-choline positr...
Prostate cancer (PC) is the second most common cancer in men worldwide, affecting ~12%. Although mos...
PURPOSE: To determine the clinical value of two novel molecular imaging techniques: (11)C-choline po...
Introduction: Lymph node metastases (LNM) represent a proven prognostic factor for biochemical recur...
Background: Radiation treatment with simultaneous integrated boost against suspected lymph node meta...
BACKGROUND: Contrast-enhanced computed tomography (CT) and magnetic resonance (MR) imaging for lymph...
Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and the leading cause of ca...
Objectives: We aimed to study the ability of contrast enhanced MRI at 1.5 T and C-11-acetate PET/CT,...
PURPOSE: The detection of lymph-node metastases (N1) with conventional imaging such as magnetic reso...
BACKGROUND: Contrast-enhanced computed tomography (CT) and magnetic resonance (MR) imaging for lymph...
Background Accurate local staging is critical for treatment planning and prognosis in patients with ...
Despite early detection programs, many patients with prostate cancer present with intermediate- or h...